Biden Administration Backs Vaccine Intellectual Property Waiver
Biden Administration Backs Vaccine Intellectual Property Waiver
The move, which is not supported by the pharmaceutical industry, would allow other countries to design and manufacture COVID-19 vaccines without fear of litigation.
Biden Administration Backs Vaccine Intellectual Property Waiver
Biden Administration Backs Vaccine Intellectual Property Waiver

The move, which is not supported by the pharmaceutical industry, would allow other countries to design and manufacture COVID-19 vaccines without fear of litigation.

The move, which is not supported by the pharmaceutical industry, would allow other countries to design and manufacture COVID-19 vaccines without fear of litigation.

intellectual property
Foreign Researchers Accused of Hiding Links to Chinese Military
Foreign Researchers Accused of Hiding Links to Chinese Military
Amanda Heidt | Jul 24, 2020
Four Chinese nationals have been charged with visa fraud after revelations that they sent information on the layout of US labs and research carried out by colleagues back to China.
US Looks to Block Chinese Grad Students’ and Researchers’ Visas
US Looks to Block Chinese Grad Students’ and Researchers’ Visas
Ashley Yeager | May 28, 2020
Administration officials and lawmakers say the move is to shore up national security threats, but university professors argue such cancellations represent targeted discrimination.
Opinion: Stop Private Speculation in COVID-19 Research
Opinion: Stop Private Speculation in COVID-19 Research
Emiliano Brancaccio, Ugo Pagano | Mar 23, 2020
We present an economic plan for a collective sharing of scientific knowledge on the pandemic.
Grad Student Arrested Trying to Smuggle Specimens to China
Grad Student Arrested Trying to Smuggle Specimens to China
Kerry Grens | Jan 2, 2020
Prosecutors say two other researchers from the same cancer lab at Beth Israel Deaconess Medical Center successfully stole material and brought it to China.
Congress Set to Form Groups to Protect US Research Security
Congress Set to Form Groups to Protect US Research Security
Emily Makowski | Dec 11, 2019
The National Defense Authorization Act calls for a new task force and roundtable to limit foreign government involvement in federally funded research.
A Brief Guide to the Current CRISPR Landscape
A Brief Guide to the Current CRISPR Landscape
Diana Kwon | Jul 15, 2019
Hundreds of CRISPR patents have been granted around the world, and the number of applications continues to grow at a rapid pace.
USPTO Restarts CRISPR Patent Dispute Between Broad and UC
USPTO Restarts CRISPR Patent Dispute Between Broad and UC
Jef Akst | Jun 26, 2019
The US patent office declares an interference between the intellectual property held by the Broad Institute and several patent applications filed by the University of California—opposite its previous ruling.
US-China Tensions Leave Some Researchers on Edge
US-China Tensions Leave Some Researchers on Edge
Diana Kwon | Jun 7, 2019
Changing policy has left academics uncertain about what is legal for foreign involvement in research, and increased hostility and bureaucracy have led students and scholars to seek opportunities elsewhere.
Chinese-American Scientist Societies Fear Racial Profiling
Chinese-American Scientist Societies Fear Racial Profiling
Ruth Williams | Mar 21, 2019
Scientists argue that anti-Chinese political rhetoric and policies could harm US research.
Federal Court Sides with Broad in CRISPR Patent Dispute
Federal Court Sides with Broad in CRISPR Patent Dispute
Jef Akst | Sep 10, 2018
The higher court’s decision to uphold the ruling of the Patent Trial and Appeal Board essentially ends the intellectual property battle in the US.
Trump Administration Considers Restrictions on Chinese Researchers
Trump Administration Considers Restrictions on Chinese Researchers
Diana Kwon | May 2, 2018
The proposed limitations stem from fears of intellectual property theft.
How to Successfully Collaborate with Industry
How to Successfully Collaborate with Industry
Ashley P. Taylor | Mar 1, 2018
In efforts to translate basic-science results into pharmaceuticals and other technologies, success cannot be taken for granted.
Flux and Uncertainty in the CRISPR Patent Landscape
Flux and Uncertainty in the CRISPR Patent Landscape
Aggie Mika | Oct 1, 2017
The battle for the control of the intellectual property surrounding CRISPR-Cas9 is as storied and nuanced as the technology itself.
UC Berkeley: Patent Office “Ignored Key Evidence”
UC Berkeley: Patent Office “Ignored Key Evidence”
Jef Akst | Jul 26, 2017
The University of California files a brief in its appeal challenging the ruling that the Broad Institute’s group would retain its CRISPR genome-editing patent.
UC Berkeley Receives CRISPR Patent in Europe
UC Berkeley Receives CRISPR Patent in Europe
Jef Akst | Mar 24, 2017
The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.
Broad Wins CRISPR Patent Interference Case
Broad Wins CRISPR Patent Interference Case
Jef Akst | Feb 15, 2017
The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.
Notable Science Quotes
Notable Science Quotes
The Scientist Staff | Feb 1, 2017
Intellectual property theft, gun violence, scientific failure, and more
Infographic: Repurposing Strategies
Infographic: Repurposing Strategies
Anna Azvolinsky | Dec 31, 2016
Novel uses for existing and failed drugs may save companies time and money in bringing new therapeutics to market.
Life Science Controversies of 2016
Life Science Controversies of 2016
Bob Grant, Jef Akst, Tracy Vence | Dec 23, 2016
This year, the developers of CRISPR gene-editing technology argued over patent rights, a researcher fought to unmask anonymous PubPeer commenters, US regulators considered “three-parent” babies, and troubles continued for Theranos.